356 related articles for article (PubMed ID: 16673195)
1. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.
Cunningham CO; Sohler NL; McCoy K; Kunins HV
Fam Med; 2006 May; 38(5):336-40. PubMed ID: 16673195
[TBL] [Abstract][Full Text] [Related]
2. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
Turner BJ; Laine C; Lin YT; Lynch K
Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
[TBL] [Abstract][Full Text] [Related]
3. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
Nwokeji ED; Rascati KL; Brown CM; Eisenberg A
Clin Ther; 2007; 29 Suppl():2589-602. PubMed ID: 18164924
[TBL] [Abstract][Full Text] [Related]
4. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
Stock C; Shum JH
J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
[TBL] [Abstract][Full Text] [Related]
5. Managing opioid addiction with buprenorphine.
Donaher PA; Welsh C
Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
[TBL] [Abstract][Full Text] [Related]
6. Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic.
James JR; Gordon LM; Klein JW; Merrill JO; Tsui JI
Subst Abus; 2019; 40(1):11-13. PubMed ID: 29578857
[No Abstract] [Full Text] [Related]
7. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.
Mintzer IL; Eisenberg M; Terra M; MacVane C; Himmelstein DU; Woolhandler S
Ann Fam Med; 2007; 5(2):146-50. PubMed ID: 17389539
[TBL] [Abstract][Full Text] [Related]
8. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
[TBL] [Abstract][Full Text] [Related]
9. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
[TBL] [Abstract][Full Text] [Related]
10. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence.
Kissin W; McLeod C; Sonnefeld J; Stanton A
J Addict Dis; 2006; 25(4):91-103. PubMed ID: 17088229
[TBL] [Abstract][Full Text] [Related]
11. [Questionnaire study of general practitioners regarding experience and attitude to opioid substitution therapy].
Mravcík V; Coufalová M; Popov P; Zábranský T; Procházka R
Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):27-33. PubMed ID: 15810140
[TBL] [Abstract][Full Text] [Related]
12. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco.
Potter M; Schafer S; Gonzalez-Mendez E; Gjeltema K; Lopez A; Wu J; Pedrin R; Cozen M; Wilson R; Thom D; Croughan-Minihane M
J Fam Pract; 2001 Feb; 50(2):145-51. PubMed ID: 11219563
[TBL] [Abstract][Full Text] [Related]
13. Using buprenorphine for outpatient opioid detoxification.
Manlandro JJ
J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine for office-based treatment of patients with opioid addiction.
Manlandro JJ
J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
[TBL] [Abstract][Full Text] [Related]
15. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.
Arfken CL; Johanson CE; di Menza S; Schuster CR
J Subst Abuse Treat; 2010 Sep; 39(2):96-104. PubMed ID: 20598829
[TBL] [Abstract][Full Text] [Related]
16. Training HIV physicians to prescribe buprenorphine for opioid dependence.
Sullivan LE; Tetrault J; Bangalore D; Fiellin DA
Subst Abus; 2006 Sep; 27(3):13-8. PubMed ID: 17135176
[TBL] [Abstract][Full Text] [Related]
17. Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration.
Gordon AJ; Kavanagh G; Krumm M; Ramgopal R; Paidisetty S; Aghevli M; Goodman F; Trafton J; Liberto J
Psychol Addict Behav; 2011 Jun; 25(2):215-24. PubMed ID: 21480679
[TBL] [Abstract][Full Text] [Related]
18. Exploring beliefs and practice of opioid prescribing for persistent non-cancer pain by general practitioners.
Hutchinson K; Moreland AM; de C Williams AC; Weinman J; Horne R
Eur J Pain; 2007 Jan; 11(1):93-8. PubMed ID: 16487734
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
20. Training rural practitioners to use buprenorphine; using The Change Book to facilitate technology transfer.
McCarty D; Rieckmann T; Green C; Gallon S; Knudsen J
J Subst Abuse Treat; 2004 Apr; 26(3):203-8. PubMed ID: 15063914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
